NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

New Delhi-based Morepen Laboratories is in talks with Ajay Piramal Group to sell its OTC (over-the-counter) business of market leading brands such as Burnol as it plans to monetise some of its mainstream brands when larger rivals look to expand their consumer product portfolio. Morepen has mandated Deloitte Touche Tohmatsu…

news

A new drug to treat a rare inherited bone disorder that was developed by Alexion Pharmaceuticals and could cost up to 1.5 million pounds ($2 million) a year per patient has been cleared for limited use by Britain's health cost watchdog. The National Institute for Health and Care Excellence (NICE),…

news

Turing Pharmaceuticals AG announces development of new drug candidates for Toxoplasmosis. Clinical trials with new compounds are expected to begin in 2h 2017. Turing pharmaceuticals says initiated regulatory safety studies and pharmaceutical development activities needed for an IND to FDA.   Source : reuters.com

news

U.S. lawmakers on Wednesday blasted Mylan NV Chief Executive Heather Bresch for sharply increasing prices for the EpiPen emergency allergy treatment at a congressional hearing in which Republicans and Democrats questioned the reasons behind rising U.S. drug costs. The House Committee on Oversight and Government Reform called Bresch to testify…

news

UnitedHealth Group Inc, the largest U.S. health insurer, will stop covering several brand-name drugs as of next year, reinforcing a trend of payers steering prescriptions to lower-priced options. In a bulletin seeking client feedback by Sept. 28, UnitedHealth said it is changing reimbursement terms for long-acting insulins and will no…

news

Galmed Pharmaceuticals' shares surged by a quarter after Allergan (AGN.N) said it would pay up to $1.7 billion for Tobira Therapeutics (TBRA.O), which like Galmed is developing a therapy for NASH, a fatty liver disease linked to obesity. There are no approved treatments for NASH (nonalcoholic steatohepatitis), an incurable disease…

news

Botox maker Allergan Plc, in its third acquisition this month, said it would pay up to $1.7 billion for Tobira Therapeutics Inc to get a leg up in the race to develop therapies for NASH, an incurable fatty liver disease closely linked to obesity. Just hours later on Tuesday, Allergan…

news

GlaxoSmithKline said on Tuesday it had chosen its head of consumer healthcare, Emma Walmsley, as its new chief executive, after several months reviewing internal and external candidates. She will become the first woman to head a top global pharmaceutical company and will bring the number of female chief executives in…

news

Mylan NV (MYL.O) faced new scrutiny over price hikes for its anti-allergy EpiPen on Tuesday, with U.S. lawmakers calling for a probe of oversight of the company’s rebates to government healthcare plans, while West Virginia said it was investigating whether Mylan defrauded its Medicaid department. Mylan is grappling with a…

news

Bowing to pressure from patient advocates, the U.S. Food and Drug Administration on Monday approved a treatment for Duchenne muscular dystrophy even though an outside panel of experts and the agency's own reviewers questioned the drug's efficacy. The FDA's lead reviewer, Dr. Ronald Farkas, recently quit the agency after issuing…